PARADIGM Trademark

Trademark Overview

On Friday, November 1, 2024, a trademark application was filed for PARADIGM with the United States Patent and Trademark Office. The USPTO has given the PARADIGM trademark a serial number of 98832385. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, March 27, 2025. This trademark is owned by Cybin Corp.. The PARADIGM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Product research and development in the field of major depressive disorders and other mental health disorders; Providing medical and scientific research information in the field of clinical trials
paradigm

General Information

Serial Number98832385
Word MarkPARADIGM
Filing DateFriday, November 1, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateThursday, March 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical drug development services; Product research and development in the field of major depressive disorders and other mental health disorders; Providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCybin Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1C9
CA

Trademark Events

Event DateEvent Description
Friday, November 1, 2024NEW APPLICATION ENTERED
Friday, November 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 27, 2025ASSIGNED TO EXAMINER

Related Keywords

paradigm field research disorders development medical providing scientific clinical trials health